TITLE

'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease

AUTHOR(S)
Schaan, Beatriz D.; Quadros, Alexandre S.; Sarmento-Leite, Rogério; De Lucca, Jr., Giuseppe; Bender, Alexandra; Bertoluci, Marcello
PUB. DATE
January 2007
SOURCE
Cardiovascular Diabetology;2007, Vol. 6, p19
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). Methods: Patients (n = 135, 30-80 years) referred for coronary angiography were submitted to clinical and laboratory evaluation, and the coronary angiograms were evaluated by two operators blinded to clinical characteristics. CAD was defined as the presence of a 70% stenosis in one major coronary artery, and DM was characterized as a fasting glycemia > 126 mg/dl or known diabetics (personal history of diabetes or previous use of anti-hyperglycemic drugs or insulin). Based on these criteria, study patients were classified into four groups: no DM and no CAD (controls, C n = 61), DM without CAD (D n = 23), CAD without DM (C-CAD n = 28), and CAD with DM (D-CAD n = 23). Baseline differences between the 4 groups were evaluated by the χ ² test for trend (categorical variables) and by ANOVA (continuous variables, post-hoc Tukey). Patients were then followed-up during two years for the occurrence of MACE (cardiac death, stroke, myocardial infarction or myocardial revascularization). The association of candidate variables with the occurrence of 2-year MACE was assessed by univariate analysis. Results: The mean age was 58.2 ± 0.9 years, and 51% were men. Patients with CAD had a higher mean age (p = 0.011) and a higher percentage were male (p = 0.040). There were no significant baseline differences between the 4 groups regarding hypertension, smoking status, blood pressure levels, lipid levels or inflammatory markers. TGF-β1 was similar between patients with or without CAD or DM (35.1 ×/÷ 1.3, 33.6 ×/÷ 1.6, 33.9 ×/÷ 1.4 and 31.8 ×/÷ 1.4 ng/ml in C, D, C-CAD and D-CAD, respectively, p = 0.547). In the 2-year follow-ip, independent predictors of 2-year MACE were age (p = 0.007), C-reactive protein (p = 0.048) and systolic blood pressure (p = 0.008), but not TGF-β1. Conclusion: Serum TGF-β1 was not associated with CAD or MACE occurrence in patients with or without DM.
ACCESSION #
28682829

 

Related Articles

  • Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: A prospective study in 716 patients over 8 years. Becker, Alexander; Leber, Alexander W.; Becker, Christoph; von Ziegler, Franz; Tittus, Janine; Schnoeder, Ines; Steinbeck, Gerhard; Knez, Andreas // BMC Cardiovascular Disorders;2008, Vol. 8, Special section p1 

    Background: To establish an efficient prophylaxis of coronary artery disease reliable risk stratification is crucial, especially in the high risk population of patients suffering from diabetes mellitus. This prospective study determined the predictive value of coronary calcifications for future...

  • Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Wu, Yang; Xia, Zhong-yuan; Dou, Juan; Zhang, Li; Xu, Jin-jin; Zhao, Bo; Lei, Shaoqing; Liu, Hui-min // Molecular Biology Reports;Oct2011, Vol. 38 Issue 7, p4327 

    The objective of the current study is to investigate whether ginsenoside Rb1, a major pharmacological extract of ginseng that could attenuate myocardial ischemia reperfusion (MI/R) injury in non-diabetic myocardium, can attenuate MI/R injury in diabetes that are more vulnerable to ischemic...

  • Is it an AMI or not? Get the whole story.  // ED Nursing;Apr2010, Vol. 13 Issue 6, p63 

    The article presents suggestions by various medical practitioners regarding medical care of patients with myocardial infarction. Cathy C. Fox, clinical nurse educator says that the patient's color and skin should be examined in case of high respiratory rate. Clinical educator Tracy Simmons says...

  • Review: Diabetes is not a coronary disease equivalent. Farkouh, Michael E.; Idris, I. // ACP Journal Club;8/18/2009, Vol. 151 Issue 2, p4 

    The article reports that patients with diabetes and no history of myocardial infarction (MI) have a lower risk for coronary artery disease (CAD) events than patients with previous MI and no diabetes. Included studies compared risk for CAD events in patients with diabetes and no MI and patients...

  • Interplay of diabetes and coronary heart disease on cardiovascular mortality. Boccara, F.; Cohen, A. // Heart;Dec2004, Vol. 90 Issue 12, p1371 

    Patients with both diabetes mellitus and prior myocardial infarction are at particularly high risk for cardivascular mortality

  • Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Acampa, Wanda; Petretta, Mario; Evangelista, Laura; Daniele, Stefania; Xhoxhi, Evgjeni; Rimini, Maria; Cittanti, Corrado; Marranzano, Filippo; Spadafora, Marco; Baldari, Sergio; Mansi, Luigi; Cuocolo, Alberto // European Journal of Nuclear Medicine & Molecular Imaging;Mar2012, Vol. 39 Issue 3, p387 

    Purpose: To determine whether stress-rest myocardial perfusion single-photon emission (MPS) computed tomography improves coronary heart disease (CHD) risk classification in diabetic patients. Methods: In 822 consecutive diabetic patients, risk estimates for a CHD event were categorized as 0% to...

  • Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21. Gioli-Pereira, Luciana; Caleb Junior Lima Santos, Paulo; Evangelista Ferreira, Noely; Armindo Hueb, Whady; Eduardo Krieger, Jose; Costa Pereira, Alexandre // BMC Cardiovascular Disorders;2012, Vol. 12 Issue 1, p61 

    Background: We investigated whether 9p21 polymorphisms are associated with cardiovascular events in a group of 611 patients enrolled in the Medical, Angioplasty or Surgery Study II (MASS II), a randomized trial comparing treatments for patients with coronary artery disease (CAD) and preserved...

  • IMPACT OF DIABETES ON EARLY COMPLICATIONS IN ACUTE CORONARY SYNDROME PATIENTS. Ali, Muzaffar; Butt, Usman Mahmood; Akram, Zubair; Qureshi, Mamoon Akbar // Pakistan Heart Journal;2016, Vol. 49 Issue 3, p113 

    Objective: To compare in-hospital complications among diabetics and non-diabetics presenting with acute coronary syndrome. Methodology: This cross-sectional survey was conducted at Department of Cardiology, Jinnah Hospital, Lahore from January 2014 to July 2014. Patients with ACS were enrolled...

  • Coronary Artery Disease -- Myocardial Infarction.  // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 2, p47 

    Presents abstracts of studies on myocardial infarction. "Occurrence of Non-Q Wave Myocardial Infarction Following Percutaneous Coronary Intervention in the Stent Era: Systematic Monitoring of the Three Markers of Myocardial Infarction," by E. Varani et al, published in a 2005 issue of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics